X4 Pharmaceuticals, Inc.
CXCR4 inhibitors and uses thereof
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
21 Jun 2017
Issue date:
17 May 2022